129 studies found for:    "Gallbladder Diseases"
Show Display Options
Rank Status Study
21 Terminated Operating Room Outcomes After Resident Training on a Virtual Reality Simulator
Condition: Gall Bladder Disease
Intervention: Behavioral: laparoscopic training curriculum
22 Completed Investigating Three-Dimensional Versus Two-Dimensional Imaging in Laparoscopic Cholecystectomies
Condition: Gall Bladder Disease
Intervention: Device: Laparoscopic visual system
23 Not yet recruiting 3D HD Versus 2D HD in Cholecystectomy
Conditions: Cholelithiasis;   Gall Bladder Disease
Interventions: Device: 3D HD laparoscopy;   Device: 2D HD laparoscopy
24 Unknown  Prospective Multicenter Human Randomized Controlled Evaluation of NOTES® Cholecystectomy
Condition: Gall Bladder Diseases
Interventions: Procedure: NOTES Cholecystectomy;   Procedure: Laparoscopic Cholecystectomy
25 Recruiting Los Angeles Prospective GI Biliary and EUS Series
Conditions: Biliary Disease;   Pancreatitis;   Gastrointestinal Neoplasms
Intervention: Other: clinical course
26 Recruiting Laparoscopy-assisted ERCP in Patients With Altered Gastric Anatome
Conditions: Biliary Disease;   Pancreas Disease
Intervention: Procedure: Laparoscopy assisted ERCP
27 Completed Single-operator Wire-guided Endoscopic Retrograde Cholangiopancreatography Cannulation Technique
Conditions: Biliary Diseases;   Pancreas Diseases
Interventions: Procedure: Team 1;   Procedure: Team 2
28 Unknown  Transient ECG Changes in Patients With Acute Biliary Disease
Conditions: Acute Cholecystitis;   Biliary Colic;   Acute Cholangitis
Intervention:
29 Recruiting 3D vs 2D HD Laparoscopy in Cholecystectomy
Condition: Cholecystolithiasis
Interventions: Procedure: 2D laparoscopic cholecystectomy;   Procedure: 3D laparoscopic cholecystectomy
30 Completed
Has Results
Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors
Conditions: Cholangiocarcinoma of the Extrahepatic Bile Duct;   Cholangiocarcinoma of the Gallbladder;   Gastrointestinal Cancer;   Recurrent Extrahepatic Bile Duct Cancer;   Recurrent Gallbladder Cancer;   Unresectable Extrahepatic Bile Duct Cancer;   Unresectable Gallbladder Cancer
Interventions: Drug: erlotinib hydrochloride;   Biological: bevacizumab
31 Completed Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
Conditions: Advanced Adult Primary Liver Cancer;   Anaplastic Thyroid Cancer;   Bone Metastases;   Carcinoma of the Appendix;   Distal Urethral Cancer;   Fallopian Tube Cancer;   Gastrinoma;   Glucagonoma;   Inflammatory Breast Cancer;   Insulinoma;   Liver Metastases;   Localized Unresectable Adult Primary Liver Cancer;   Lung Metastases;   Male Breast Cancer;   Malignant Pericardial Effusion;   Malignant Pleural Effusion;   Metastatic Gastrointestinal Carcinoid Tumor;   Metastatic Parathyroid Cancer;   Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter;   Newly Diagnosed Carcinoma of Unknown Primary;   Occult Non-small Cell Lung Cancer;   Pancreatic Polypeptide Tumor;   Primary Peritoneal Cavity Cancer;   Proximal Urethral Cancer;   Pulmonary Carcinoid Tumor;   Recurrent Adenoid Cystic Carcinoma of the Oral Cavity;   Recurrent Adrenocortical Carcinoma;   Recurrent Adult Primary Liver Cancer;   Recurrent Anal Cancer;   Recurrent Bladder Cancer;   Recurrent Breast Cancer;   Recurrent Carcinoma of Unknown Primary;   Recurrent Cervical Cancer;   Recurrent Colon Cancer;   Recurrent Endometrial Carcinoma;   Recurrent Esophageal Cancer;   Recurrent Extrahepatic Bile Duct Cancer;   Recurrent Gallbladder Cancer;   Recurrent Gastric Cancer;   Recurrent Gastrointestinal Carcinoid Tumor;   Recurrent Islet Cell Carcinoma;   Recurrent Malignant Testicular Germ Cell Tumor;   Recurrent Mucoepidermoid Carcinoma of the Oral Cavity;   Recurrent Non-small Cell Lung Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Pancreatic Cancer;   Recurrent Parathyroid Cancer;   Recurrent Prostate Cancer;   Recurrent Rectal Cancer;   Recurrent Renal Cell Cancer;   Recurrent Salivary Gland Cancer;   Recurrent Small Intestine Cancer;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Thyroid Cancer;   Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter;   Recurrent Urethral Cancer;   Recurrent Vaginal Cancer;   Recurrent Vulvar Cancer;   Skin Metastases;   Small Intestine Adenocarcinoma;   Somatostatinoma;   Stage III Adenoid Cystic Carcinoma of the Oral Cavity;   Stage III Adrenocortical Carcinoma;   Stage III Bladder Cancer;   Stage III Cervical Cancer;   Stage III Colon Cancer;   Stage III Endometrial Carcinoma;   Stage III Esophageal Cancer;   Stage III Follicular Thyroid Cancer;   Stage III Gastric Cancer;   Stage III Malignant Testicular Germ Cell Tumor;   Stage III Mucoepidermoid Carcinoma of the Oral Cavity;   Stage III Ovarian Epithelial Cancer;   Stage III Pancreatic Cancer;   Stage III Papillary Thyroid Cancer;   Stage III Prostate Cancer;   Stage III Rectal Cancer;   Stage III Renal Cell Cancer;   Stage III Salivary Gland Cancer;   Stage III Squamous Cell Carcinoma of the Larynx;   Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage III Squamous Cell Carcinoma of the Nasopharynx;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage III Vaginal Cancer;   Stage III Vulvar Cancer;   Stage IIIA Anal Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Anal Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Adenoid Cystic Carcinoma of the Oral Cavity;   Stage IV Adrenocortical Carcinoma;   Stage IV Anal Cancer;   Stage IV Bladder Cancer;   Stage IV Breast Cancer;   Stage IV Colon Cancer;   Stage IV Endometrial Carcinoma;   Stage IV Esophageal Cancer;   Stage IV Follicular Thyroid Cancer;   Stage IV Gastric Cancer;   Stage IV Mucoepidermoid Carcinoma of the Oral Cavity;   Stage IV Non-small Cell Lung Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Pancreatic Cancer;   Stage IV Papillary Thyroid Cancer;   Stage IV Prostate Cancer;   Stage IV Rectal Cancer;   Stage IV Renal Cell Cancer;   Stage IV Salivary Gland Cancer;   Stage IV Squamous Cell Carcinoma of the Larynx;   Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Cervical Cancer;   Stage IVA Vaginal Cancer;   Stage IVB Cervical Cancer;   Stage IVB Vaginal Cancer;   Stage IVB Vulvar Cancer;   Thyroid Gland Medullary Carcinoma;   Unresectable Extrahepatic Bile Duct Cancer;   Unresectable Gallbladder Cancer;   Urethral Cancer Associated With Invasive Bladder Cancer;   WDHA Syndrome
Interventions: Biological: recombinant interleukin-12;   Biological: ABI-007/carboplatin/trastuzumab
32 Unknown  Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy
Condition: Cholecystolithiasis
Interventions: Drug: Gabapentin;   Drug: S-ketamine;   Drug: Lidocaine;   Drug: Droperidol
33 Completed Does Cholecystectomy Increase the Esophageal Alkaline Reflux? Evaluation by Impedance-pH Technique
Conditions: Cholecystolithiasis;   Cholecystectomy;   Gastroesophageal Reflux
Intervention: Procedure: impedance pH measurement
34 Recruiting Dual-Loop Target Controlled Infusion in Laparoscopic Cholecystectomy (DLTCI)
Condition: Cholecystolithiasis
Interventions: Device: Dual-loop TCI;   Device: manual
35 Terminated Single-Incision Laparoscopic Cholecystectomy Versus Traditional Laparoscopic Cholecystectomy
Conditions: Biliary Dyskinesia;   Gallstones;   Cholecystitis;   Cholelithiasis
Interventions: Procedure: Single-Incision Laparoscopic Surgery cholecystectomy;   Procedure: Traditional Laparoscopic Cholecystectomy (TLC)
36 Completed Robotic Assisted Versus Laparoscopic Cholecystectomy - Outcome and Cost Analyses of a Case-Matched Control Study
Condition: Cholecystolithiasis
Interventions: Procedure: robotic assisted cholecystectomy;   Procedure: Laparoscopic cholecystectomy
37 Completed Oxidative Stress in Standard Laparoscopic vs Single Port Cholecystectomy
Conditions: Uncomplicated Cholelithiasis;   Cholecystectomy;   Laparoscopy;   Standard Technique;   Single Port Laparoscopy
Interventions: Other: Laparoscopic cholecystectomy;   Other: Single incision laparoscopic cholecystectomy
38 Suspended Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery
Conditions: Adult Cholangiocarcinoma;   Advanced Adult Hepatocellular Carcinoma;   BCLC Stage C Adult Hepatocellular Carcinoma;   BCLC Stage D Adult Hepatocellular Carcinoma;   Hilar Cholangiocarcinoma;   Localized Non-Resectable Adult Liver Carcinoma;   Recurrent Adult Liver Carcinoma;   Recurrent Childhood Liver Cancer;   Recurrent Extrahepatic Bile Duct Carcinoma;   Recurrent Gallbladder Carcinoma;   Stage II Gallbladder Cancer;   Stage III Childhood Hepatocellular Carcinoma;   Stage IIIA Gallbladder Cancer;   Stage IIIB Gallbladder Cancer;   Stage IV Childhood Hepatocellular Carcinoma;   Stage IV Distal Bile Duct Cancer;   Stage IVA Gallbladder Cancer;   Stage IVB Gallbladder Cancer;   Unresectable Extrahepatic Bile Duct Carcinoma
Interventions: Drug: Trametinib;   Drug: Leucovorin Calcium;   Drug: Fluorouracil;   Drug: Capecitabine;   Other: Laboratory Biomarker Analysis
39 Completed Prospective Trial for Endoscopic Ultrasound Guided Gallbladder Drainage for Acute Cholecystitis in High Risk Patients
Condition: Cholecystitis
Interventions: Procedure: EUS-guided gallbladder drainage;   Procedure: percutaneous transhepatic gallbladder drainage
40 Recruiting Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree Cancer
Conditions: Cholangiocarcinoma;   Gallbladder Carcinoma;   Biliary Carcinoma
Intervention: Drug: Gemcitabine-Pazopanib

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years